Search

Author/Creator Stevanovic, Amanda

3. Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an international, open-label, randomised, phase 3 trial. Issue 4 (April 2023)

Authors:
Sweeney, Christopher J; Martin, Andrew J; Stockler, Martin R; Begbie, Stephen; Cheung, Leanna; Chi, Kim N; Chowdhury, Simon; Frydenberg, Mark; Horvath, Lisa G; Joshua, Anthony M; Lawrence, Nicola J; Marx, Gavin; McCaffrey, John; McDermott, Ray; McJannett, Margaret; North, Scott A; Parnis, Francis...
Journal:
Lancet oncology
Issue:
Volume 24:Issue 4(2023)
Page Start:
323
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗